M. Maitituoheti

发表

Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressor

Fei Yang, A. Sahin, Siddhartha Roy, 2019, Nature Communications.

Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer

Jeffrey S. Morris, Kyle Chang, K. Tomczak, 2020, Gut.

Association of an oestrogen receptor gene polymorphism in Chinese Han women with endometriosis and endometriosis-related infertility.

D. Ma, Shixuan Wang, M. Maitituoheti, 2013, Reproductive biomedicine online.

The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma

P. A. Futreal, Hannah C. Beird, A. Lazar, 2022, Nature Communications.

Soluble B and T Lymphocyte Attenuator Possesses Antitumor Effects and Facilitates Heat Shock Protein 70 Vaccine-Triggered Antitumor Immunity against a Murine TC-1 Cervical Cancer Model In Vivo1

Daowen Wang, Yong Fang, L. Meng, 2009, The Journal of Immunology.

Antitumor Immunity against a Murine TC-1 Heat Shock Protein 70 Vaccine-Triggered Possesses Antitumor Effects and Facilitates Soluble B and T Lymphocyte Attenuator

Daowen Wang, Yong Fang, L. Meng, 2009 .

Enhancer Reprogramming in Melanoma Immune Checkpoint Therapy Resistance

Jared C Malke, Manolis Kellis, J. Wargo, 2022, bioRxiv.

KMT2D deficiency confers a therapeutic vulnerability to glycolytic and IGFR inhibitors in melanoma

M. Maitituoheti, Navya Murugesan, 2021, Molecular & cellular oncology.

Adeno-associated Virus-mediated Local Delivery of LIGHT Suppresses Tumorigenesis in a Murine Cervical Cancer Model

D. Ma, Shixuan Wang, M. Maitituoheti, 2011, Journal of immunotherapy.

KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer.

Min Gyu Lee, F. Muller, E. Flores, 2020, Cancer cell.

Super-enhancer impairment is a link between MLL4-inactivated lung tumors and their vulnerability to glycolysis pathway inhibition

Min Gyu Lee, F. Muller, F. DeMayo, 2018 .

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues.

Zhiyi Liu, Christopher Terranova, Ming Tang, 2018, Journal of visualized experiments : JoVE.

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

K. Tomczak, A. Lazar, S. Woodman, 2021, Cell reports.

H3K4me1-marked Enhancer Activation in Resistant Prostate Cancers Implicates SOX4 and MENIN Inhibition as Therapeutic Strategies

P. Troncoso, C. Logothetis, T. Thompson, 2021, bioRxiv.

Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway

Shixuan Wang, M. Maitituoheti, Yan Li, 2014, Oncology letters.

Bivalent and Broad Chromatin Domains Regulate Pro-metastatic Drivers in Melanoma

K. Tomczak, A. Lazar, S. Woodman, 2019, bioRxiv.

The Androgen Receptor: A Therapeutic Target in Desmoplastic Small Round Cell Sarcoma

P. A. Futreal, Hannah C. Beird, A. Lazar, 2022, bioRxiv.

Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression.

I. Amit, L. Chin, B. Garcia, 2017, Cell reports.

Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma

Min Gyu Lee, Guangchun Han, E. Keung, 2018, bioRxiv.

EMDomics: a robust and powerful method for the identification of genes differentially expressed between heterogeneous classes

Andrew H. Beck, Sheida Nabavi, Daniel Schmolze, 2015, Bioinform..

Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressor

Fei Yang, A. Sahin, Siddhartha Roy, 2019, Nature Communications.

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues.

Ayush T. Raman, S. Amin, Kunal Rai, 2018, Journal of visualized experiments : JoVE.

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

K. Tomczak, A. Lazar, S. Woodman, 2021, Cell reports.